Hemostatic Agents Market

The market for Hemostatic Agents had a value of USD 4.08 Billion in 2023 and is estimated to reach USD 6.24 Billion by 2030, exhibiting a CAGR of 5.3% from 2023 to 2030.

The growing prevalence of chronic diseases among the aging population is leading to an increased demand for hemostatic agents. With a rise in surgical procedures performed worldwide, there will be a significant need for hemostatic agents, driving the growth of the market. Furthermore, advancements in technology and the availability of technologically advanced products are also contributing to the expansion of the market. The Global Hemostatic Agents market report provides a comprehensive assessment, analyzing key segments, trends, drivers, restraints, competitive landscape, and factors that play a significant role in the market.

Global Hemostatic Agents Market Definition
Hemostasis, also known as the prevention of hemorrhage, refers to the process that stops blood from escaping a blood vessel. It occurs when a clot forms at the site of the blood vessel injury, effectively repairing it. Hemostasis comprises three main components: fibrinolysis, primary hemostasis, and secondary hemostasis. Platelets gather to form a plug that seals the damaged blood vessel, while a group of proteins called clotting factors work together to create a fibrin mesh that stabilizes the platelets. This process not only facilitates wound healing but also prevents blood from leaking out of the blood vessel.

Hemostatic drugs play a role in maintaining hemostasis by promoting clot formation and reducing blood flow, thus expediting the coagulation process. These substances enhance hemostasis by promoting primary hemostasis, increasing fibrin production, or inhibiting fibrinolysis. Hemostatic drugs are essential in the prevention or treatment of bleeding, offering various therapeutic applications.

Global Hemostatic Agents Market Overview
The increasing prevalence of bleeding disorders necessitates the use of specialized hemostatic medications. The aging population, particularly those affected by chronic diseases, is driving the demand for hemostasis drugs. As surgical interventions rise worldwide, there will be a substantial need for hemostatic agents, leading to market growth. According to the World Health Organization (WHO), car accidents result in over a million injuries annually, many of which involve severe bleeding, further fueling the demand for hemostasis medications.

The global market for hemostatic agents is also expected to be influenced by factors such as the growing elderly population and advancements in surgical techniques, including robot-assisted surgery. However, the high cost of surgical procedures and unfavorable reimbursement policies may limit market expansion. Additionally, the lack of awareness and knowledge about the latest technological advancements in developing and emerging countries could hinder the growth of the hemostatic agents market.

Global Hemostatic Agents Market Segmentation Analysis

The Global Hemostatic Agents Market is Segmented on the basis of Product Type, Treatment, End-user, And Geography.

Hemostatic Agents Market, By Product Type
• Thrombin Based Hemostats
• Gelatin Based Hemostats
• Collagen Based Hemostats
• Oxidized Regenerated Cellulose Based Hemostats
• Combination Hemostats
• Fibrin Sealants
• Others

The market is categorized into various product types, including Thrombin Based Hemostats, Combination Hemostats, Collagen Based Hemostats, Gelatin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Fibrin Sealants, and Others. Among these, the combination hemostats segment held the largest market share in 2022 and is expected to grow at a significant CAGR during the forecast period. Combination hemostats have demonstrated high effectiveness and promote faster healing. Their ability to achieve efficient hemostasis quickly is attributed to the synergistic actions of thrombin and gelatin. As the use of combination hemostats continues to increase, the global hemostasis agents market is anticipated to witness significant growth.

Hemostatic Agents Market, By Treatment
• Cardiovascular
• General Surgery
• Digestive Surgery
• Neurosurgery
• Others

The Global Hemostatic Agents Market is categorized based on treatment into Cardiovascular, General Surgery, Digestive Surgery, Neurosurgery, and Others. Among these segments, the Cardiovascular segment held the largest market share in 2022 and is expected to exhibit the highest growth rate during the forecast period. This growth can be attributed to several factors such as the increasing incidence of cardiovascular diseases necessitating surgical interventions, the rise in dietary and life-related issues, the global occurrence of traumatic events including accidents, and the overall growing prevalence of cardiovascular disorders.

Hemostatic Agents Market, By End-user
• Hospitals
• Surgery Centers
• Nursing Homes
• Others

The Global Hemostatic Agents Market is divided into different end users, including Hospitals, Surgery Centers, Nursing Homes, and others. Among these segments, the hospital segment held the largest market share in 2022 and is expected to experience the highest compound annual growth rate (CAGR) during the forecast period. This growth can be attributed to various factors such as the increasing incidence of accidents and emergencies, the establishment of advanced hospitals and clinics equipped with the latest technologies, and the growing demand for complex surgical procedures in hospital settings.

Hemostatic Agents Market, By Geography
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

The Global Hemostatic Agents Market is categorized into North America, Europe, Asia Pacific, and the Rest of the world based on regional analysis. North America emerged as the leading market in terms of market share and is anticipated to witness substantial growth at a significant compound annual growth rate (CAGR) throughout the forecast period. This dominance can be attributed to factors such as the widespread adoption of technologically advanced products and an increase in surgical procedures, which drive the demand for hemostatic agents in the region.

Key Players
The study report on the "Global Hemostatic Agents Market" will offer valuable insights focusing on the global market, including prominent players such as B.Braun Melsungen AG, Integra Life Sciences Corporation, Equimedical, Marine Polymer Technologies, Baxter International Incorporation, C.R. Bard Incorporation, Gelita GmbH, Johnson and Johnson Services Inc, Pfizer Inc, Advanced Medical Solutions Group, and others.

Additionally, our market analysis dedicates a section specifically to these major players, where our analysts provide in-depth information on their financial statements, product benchmarking, and SWOT analysis. The competitive landscape section also covers key strategies for development, market share, and market ranking analysis of the aforementioned players on a global scale.

Key Developments
• In October 2022, Creilson, Inc., a biotechnology company based in Brooklyn, successfully concluded a Series A-4 financing round, raising USD 25 million. The funding, led by Paulson Investment Company, will be utilized to expedite the launch of their innovative hemostatic gel, VETIGEL, in the human health market. The company had previously submitted a 510(k) premarket notification to the US Food and Drug Administration.
• In July 2021, Baxter International Inc. acquired certain assets of the PerClot Polysaccharide Hemostatic System from CryoLife for a total of up to USD 60.8 million.

Ace Matrix Analysis
The Ace Matrix included in the report offers insights into the performance of key players in the industry. We assess these companies based on factors such as service features & innovations, scalability, industry coverage, industry reach, and growth roadmap. Using this assessment, we categorize the companies into four groups: Active, Cutting Edge, Emerging, and Innovators, providing a comprehensive understanding of their standing in the market.

Market Attractiveness
The market attractiveness visualization included in the report provides valuable information about the leading region in the Global Hemostatic Agents Market. We analyze the major factors that contribute to the growth of the industry in that specific region.

Porter’s Five Forces
The visualization also includes Porter's Five Forces framework, which offers insights into the competitive landscape and strategic positioning of players in the industry. By using Porter's five forces model, we can assess the competitive dynamics in the Global Hemostatic Agents Market, evaluate the attractiveness of specific sectors, and identify investment opportunities.

Reasons to Purchase this Report:
• Thorough analysis of the market using qualitative and quantitative approaches, considering both economic and non-economic factors
• Comprehensive market value data (in USD Billion) provided for each segment and sub-segment
• Identification of the region and segment expected to experience the fastest growth and dominate the market
• Examination of product/service consumption and market factors specific to each geographic region
• Competitive landscape analysis, including market rankings of major players, recent service/product launches, partnerships, business expansions, and acquisitions in the past five years
• Detailed company profiles with insights, product benchmarking, and SWOT analysis for key market players
• Current and future market outlook, encompassing recent developments, growth opportunities, drivers, challenges, and restraints in both emerging and developed regions
• In-depth analysis of market perspectives through Porter's Five Forces analysis
• Insight into the market provided through the Value Chain analysis
• Assessment of market dynamics and growth opportunities in the coming years
• 6-month post-sales analyst support for further assistance and guidance.